A detailed history of Rhumbline Advisers transactions in Quanterix Corp stock. As of the latest transaction made, Rhumbline Advisers holds 59,704 shares of QTRX stock, worth $744,508. This represents 0.0% of its overall portfolio holdings.

Number of Shares
59,704
Previous 60,444 1.22%
Holding current value
$744,508
Previous $798,000 3.13%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$10.92 - $16.36 $8,080 - $12,106
-740 Reduced 1.22%
59,704 $773,000
Q2 2024

Aug 01, 2024

SELL
$12.26 - $23.78 $87,193 - $169,123
-7,112 Reduced 10.53%
60,444 $798,000
Q1 2024

May 09, 2024

SELL
$21.9 - $28.28 $22,819 - $29,467
-1,042 Reduced 1.52%
67,556 $1.59 Million
Q4 2023

Feb 08, 2024

BUY
$19.54 - $28.66 $37,888 - $55,571
1,939 Added 2.91%
68,598 $1.88 Million
Q3 2023

Nov 09, 2023

BUY
$21.15 - $27.96 $59,706 - $78,931
2,823 Added 4.42%
66,659 $1.81 Million
Q2 2023

Aug 08, 2023

SELL
$11.16 - $23.65 $29,462 - $62,435
-2,640 Reduced 3.97%
63,836 $1.44 Million
Q1 2023

May 11, 2023

BUY
$10.12 - $14.91 $38,324 - $56,464
3,787 Added 6.04%
66,476 $749,000
Q4 2022

Feb 14, 2023

BUY
$8.75 - $14.02 $101,500 - $162,632
11,600 Added 22.71%
62,689 $868,000
Q3 2022

Nov 10, 2022

BUY
$7.46 - $19.28 $19,515 - $50,436
2,616 Added 5.4%
51,089 $563,000
Q2 2022

Aug 11, 2022

BUY
$15.06 - $30.65 $229,966 - $468,025
15,270 Added 45.99%
48,473 $785,000
Q1 2022

May 12, 2022

BUY
$23.26 - $42.41 $19,445 - $35,454
836 Added 2.58%
33,203 $969,000
Q4 2021

Feb 10, 2022

SELL
$37.54 - $57.51 $16,555 - $25,361
-441 Reduced 1.34%
32,367 $1.37 Million
Q3 2021

Nov 12, 2021

BUY
$45.91 - $59.67 $61,335 - $79,719
1,336 Added 4.25%
32,808 $1.63 Million
Q2 2021

Aug 05, 2021

BUY
$43.3 - $67.17 $247,199 - $383,473
5,709 Added 22.16%
31,472 $1.85 Million
Q1 2021

May 06, 2021

BUY
$44.11 - $90.64 $32,067 - $65,895
727 Added 2.9%
25,763 $1.51 Million
Q4 2020

Feb 10, 2021

BUY
$33.89 - $49.88 $78,285 - $115,222
2,310 Added 10.16%
25,036 $1.16 Million
Q3 2020

Nov 12, 2020

SELL
$26.91 - $37.47 $24,434 - $34,022
-908 Reduced 3.84%
22,726 $767,000
Q2 2020

Aug 13, 2020

BUY
$19.21 - $28.53 $173,447 - $257,597
9,029 Added 61.82%
23,634 $647,000
Q1 2020

May 06, 2020

BUY
$11.17 - $28.72 $10,343 - $26,594
926 Added 6.77%
14,605 $268,000
Q4 2019

Feb 05, 2020

BUY
$19.29 - $25.52 $18,479 - $24,448
958 Added 7.53%
13,679 $323,000
Q3 2019

Oct 23, 2019

BUY
$21.72 - $35.38 $31,906 - $51,973
1,469 Added 13.06%
12,721 $279,000
Q2 2019

Aug 14, 2019

BUY
$20.59 - $35.2 $28,990 - $49,561
1,408 Added 14.3%
11,252 $380,000
Q1 2019

May 01, 2019

SELL
$17.28 - $25.83 $5,304 - $7,929
-307 Reduced 3.02%
9,844 $254,000
Q4 2018

Jan 31, 2019

BUY
$16.17 - $20.8 $164,141 - $211,140
10,151 New
10,151 $186,000

Others Institutions Holding QTRX

About Quanterix Corp


  • Ticker QTRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 36,987,600
  • Market Cap $461M
  • Description
  • Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...
More about QTRX
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.